QbD Group
    即将举办的网络研讨会

    Entering the European MedTech Market: Why One Approval Doesn't Fit All

    Building on QbD Group's Landing in Europe MedTech whitepaper, this webinar explains why EU market entry requires a fundamentally different approach than you might expect. We'll explore where home-market regulatory logic breaks down in Europe — with a specific focus on clinical evidence expectations, Notified Body interactions, and lifecycle obligations.

    2026年4月29日星期三
    3PM BST / 10AM EDT
    Medical Devices
    English

    FDA approval often creates a false sense of readiness

    For many MedTech companies, FDA or NMPA approval feels like the hard part is done. But when it comes to entering Europe, it is often just the beginning. Non-EU manufacturers frequently underestimate how different the regulatory and clinical expectations are under MDR and IVDR — and that gap shows up fast: in Notified Body pushback, in missing clinical evidence, and in timelines and costs that spiral out of control.

    This webinar cuts through the complexity. We'll show you why EU market entry demands a fundamentally different strategy and how bringing your regulatory and clinical planning together from day one is the only reliable way to stay in control of your European launch.

    What you'll learn

    • Understand why FDA or NMPA approval does not automatically translate into EU readiness.
    • Identify where regulatory and clinical expectations differ in Europe and how this impacts timelines and risk.
    • Learn how an integrated regulatory and clinical strategy enables more predictable EU market entry.

    向最优秀的人学习

    演讲者

    Our speakers bring hands-on experience in EU regulatory affairs and clinical strategy for medical devices and IVDs. They will translate the complexities of MDR and IVDR into practical, actionable guidance you can apply directly to your EU market entry journey.

    Anne-Sophie Grell

    Anne-Sophie Grell

    Business Unit Manager Regulatory Affairs - Medical Devices

    Anne-Sophie Grell is Business Unit Manager Regulatory Affairs Medical Device at QbD Group, with over two decades of experience in medical physics, diagnostic imaging, and global medical device regulation. She holds a PhD in Physics and began her career as an MRI researcher in a cancer hospital before completing a Master's in Medical Physics, where she supported quality control activities across imaging and radiotherapy. In 2010, she transitioned to the private sector, taking on leadership roles in Quality and Regulatory Affairs within the medical device industry. Over the years, she has worked closely with Competent Authorities and Notified Bodies worldwide, shaping international registration strategies and regulatory pathways. At QbD, she supports manufacturers in defining and executing robust regulatory strategies to successfully bring their medical devices to the European, US, and Asian markets.

    Petra De Geest

    Petra De Geest

    Clinical Evidence & Safety Lead

    Petra is a Clinical Evidence and Safety Lead at QbD Group with over 12 years of experience across clinical practice, clinical research, and the medical device industry. She holds a Master's degree in Sports Physiotherapy and spent 10 years in clinical practice supporting both professional and non-professional athletes before transitioning into Clinical Research, where she took on roles in Clinical Operations and Safety Management. She later served as Clinical Evaluation Lead for a medical imaging device manufacturer. At QbD, Petra combines her expertise in clinical safety and evidence generation with strategic support for manufacturers in building robust clinical documentation and navigating EU MDR requirements to successfully bring their products to the European market.

    Starts in

    43Days
    17Hours
    31Min
    49Sec

    Register here

    预约席位

    加入来自欧洲各地的生物技术领导者,获取关于首次人体试验准备的实用见解。

    43Days
    :
    17Hours
    :
    31Min
    :
    49Sec

    Discover how we can help

    Market Entry into Europe for MedTech

    Keep watching

    More webinars

    From Requirements to Code: a unified MDSW development cycle that covers all requirements 点播网络研讨会

    From Requirements to Code: a unified MDSW development cycle that covers all requirements

    Software Solutions & Services2025年1月6日

    This webinar will explore the specific requirements for various safety classifications and provide valuable insights into what Notified Bodies (NBs) and the FDA expect from your development process. Key topics will include the full development cycle, cybersecurity essentials, usability engineering, AI integration, and effective strategies for aligning agile methodologies with the strict release flows required for MDSW. Gain a deeper understanding and streamline your MDSW development process today!

    立即观看
    From Concept to Market: Comprehensive Market Access Strategies for Medical Device Software 点播网络研讨会

    From Concept to Market: Comprehensive Market Access Strategies for Medical Device Software

    Regulatory Affairs2024年12月24日

    This webinar will guide you through the essential steps of market access, effective commercialization strategies, and all the critical factors needed for a successful MDSW product launch. Whether you’re a seasoned professional or new to the field, this session will provide you with the knowledge and tools to make your MDSW vision a reality.

    立即观看

    订阅生命科学领域的最新动态

    专家观点直达您的收件箱——选择您的兴趣。

    绝无垃圾邮件。随时取消订阅。

    我们使用 Cookie 来改善您的体验

    我们使用必要的 Cookie 来保证网站功能,以及可选的分析 Cookie 来改善我们的服务。 阅读我们的 隐私政策Cookie 政策.